Generic Medicine Info
Indications and Dosage
Respiratory stimulant in acute respiratory failure
Adult: Up to 3 mg/kg/day, in 2 or3 divided doses via IV infusion with each dose being infused over 2 hr.

Respiratory stimulant in acute respiratory failure
Adult: 50-100 mg daily, given in 2 divided doses. Treatment may be intermittent.
Adverse Reactions
May cause weakness in lower extremities.
Description: Almitrine is a peripheral chemoreceptor agonist that is used as a respiratory stimulant in acute respiratory failure such as COPD. It is believed to improve oxygenation by enhancing the ventilation perfusion mismatch.
MIMS Class
Respiratory Stimulants
Disclaimer: This information is independently developed by MIMS based on Almitrine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in